{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T16:56:16Z","timestamp":1776099376213,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Nat"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00114-026-02070-x","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:22:28Z","timestamp":1769494948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study on the mechanism of Ershiwei Chenxiang Pills in the treatment of high altitude hypertension based on network pharmacology and molecular docking analysis"],"prefix":"10.1007","volume":"113","author":[{"given":"Dianzhen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengnan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuli","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tainbo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianbo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"9","key":"2070_CR21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.5551\/jat.RV17009","volume":"24","author":"H Abe","year":"2017","unstructured":"Abe H, Semba H, Takeda N (2017) The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb 24(9):884\u2013894","journal-title":"J Atheroscler Thromb"},{"key":"2070_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13080975","author":"D Colon Hidalgo","year":"2024","unstructured":"Colon Hidalgo D, Jordan M, Posey JN, Burciaga SD, Nguyen TN, Sul C et al (2024) Lung EC-SOD overexpression prevents hypoxia-induced platelet activation and lung platelet accumulation. Antioxidants (Basel, Switzerland). https:\/\/doi.org\/10.3390\/antiox13080975","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"8","key":"2070_CR1","first-page":"752","volume":"40","author":"V Hirschler","year":"2018","unstructured":"Hirschler V, Molinari C, Gonzalez C, Maccallini G, Castano LA (2018) Prevalence of hypertension in Argentinean Indigenous children living at high altitudes versus US children. Clin Experimental Hypertens (New York NY: 1993) 40(8):752\u2013757","journal-title":"Clin Experimental Hypertens (New York NY: 1993)"},{"key":"2070_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112426","volume":"249","author":"Y Hou","year":"2020","unstructured":"Hou Y, Qieni X, Li N, Bai J, Li R, Gongbao D et al (2020) Longzhibu disease and its therapeutic effects by traditional Tibetan medicine: Ershi-wei Chenxiang pills. J Ethnopharmacol 249:112426","journal-title":"J Ethnopharmacol"},{"issue":"12","key":"2070_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-016-0632-z","volume":"18","author":"J Hurtubise","year":"2016","unstructured":"Hurtubise J, McLellan K, Durr K, Onasanya O, Nwabuko D, Ndisang JF (2016) The different facets of dyslipidemia and hypertension in atherosclerosis. Curr Atheroscler Rep 18(12):82","journal-title":"Curr Atheroscler Rep"},{"issue":"21","key":"2070_CR15","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1161\/01.CIR.0000129768.35536.FA","volume":"109","author":"G Iaccarino","year":"2004","unstructured":"Iaccarino G, Ciccarelli M, Sorriento D, Cipolletta E, Cerullo V, Iovino GL et al (2004) AKT participates in endothelial dysfunction in hypertension. Circulation 109(21):2587\u20132593","journal-title":"Circulation"},{"key":"2070_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2017.09.003","volume":"183","author":"T Jain","year":"2018","unstructured":"Jain T, Nikolopoulou EA, Xu Q, Qu A (2018) Hypoxia inducible factor as a therapeutic target for atherosclerosis. Pharmacol Ther 183:22\u201333","journal-title":"Pharmacol Ther"},{"issue":"7","key":"2070_CR23","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2174\/156800908786241050","volume":"8","author":"Y Lin","year":"2008","unstructured":"Lin Y, Shi R, Wang X, Shen HM (2008) Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8(7):634\u2013646","journal-title":"Curr Cancer Drug Targets"},{"issue":"13","key":"2070_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1136\/heartjnl-2014-307158","volume":"101","author":"C Mingji","year":"2015","unstructured":"Mingji C, Onakpoya IJ, Perera R, Ward AM, Heneghan CJ (2015) Relationship between altitude and the prevalence of hypertension in Tibet: a systematic review. Heart 101(13):1054\u20131060","journal-title":"Heart"},{"issue":"20","key":"2070_CR14","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.2169\/internalmedicine.53.3030","volume":"53","author":"E Oda","year":"2014","unstructured":"Oda E (2014) Serum albumin may prevent hypertension by inhibiting angiotensin converting enzyme. Intern Med (Tokyo Japan) 53(20):2411","journal-title":"Intern Med (Tokyo Japan)"},{"issue":"8","key":"2070_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00228-015-1872-5","volume":"71","author":"GH Oliveira-Paula","year":"2015","unstructured":"Oliveira-Paula GH, Lacchini R, Fontana V, Silva PS, Biagi C, Tanus-Santos JE (2015) Polymorphisms in VEGFA gene affect the antihypertensive responses to Enalapril. Eur J Clin Pharmacol 71(8):949\u2013957","journal-title":"Eur J Clin Pharmacol"},{"key":"2070_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7421489","volume":"2018","author":"M O\u017carowski","year":"2018","unstructured":"O\u017carowski M, Miko\u0142ajczak P, Kujawski R, Wielgus K, Klejewski A, Wolski H et al (2018) Pharmacological effect of quercetin in hypertension and its potential application in pregnancy-induced hypertension: review of in vitro, in vivo, and clinical studies. Evid Based Complement Alternat Med 2018:7421489","journal-title":"Evid Based Complement Alternat Med"},{"key":"2070_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176421","author":"E Pena","year":"2020","unstructured":"Pena E, Brito J, El Alam S, Siques P (2020) Oxidative stress, kinase activity and inflammatory implications in right ventricular hypertrophy and heart failure under hypobaric hypoxia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21176421","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2070_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520903645","volume":"48","author":"C Song","year":"2020","unstructured":"Song C, Chongsuvivatwong V, Zhu Luo Bu O, Ji D, Sang Zhuo Ma B, Sriplung H (2020) Relationship between hypertension and geographic altitude: a cross-sectional survey among residents in Tibet. J Int Med Res 48(2):300060520903645","journal-title":"J Int Med Res"},{"key":"2070_CR17","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1038\/ncomms7241","volume":"6","author":"T Sumida","year":"2015","unstructured":"Sumida T, Naito AT, Nomura S, Nakagawa A, Higo T, Hashimoto A et al (2015) Complement C1q-induced activation of \u03b2-catenin signalling causes hypertensive arterial remodelling. Nat Commun 6:6241","journal-title":"Nat Commun"},{"issue":"1","key":"2070_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","volume":"145","author":"W Tao","year":"2013","unstructured":"Tao W, Xu X, Wang X, Li B, Wang Y, Li Y et al (2013) Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol 145(1):1\u201310","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"2070_CR10","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.3390\/ijms13066964","volume":"13","author":"X Xu","year":"2012","unstructured":"Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y et al (2012) A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci 13(6):6964\u201382","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2070_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129966","volume":"10","author":"S Xu","year":"2015","unstructured":"Xu S, Jiayong Z, Li B, Zhu H, Chang H, Shi W et al (2015) Prevalence and clustering of cardiovascular disease risk factors among Tibetan adults in China: a population-based study. PLoS One 10(6):e0129966","journal-title":"PLoS One"},{"issue":"1","key":"2070_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22792-3","volume":"25","author":"Y Yu","year":"2025","unstructured":"Yu Y, Peng J, Zhaxi Z, Jimei Q, Shi H, Bai G et al (2025) Epidemiological features of hypertension in a high-altitude population in Tibet, China: a cross-sectional study. BMC Public Health 25(1):1729","journal-title":"BMC Public Health"},{"key":"2070_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphar.2019.00123","volume":"10","author":"R Zhang","year":"2019","unstructured":"Zhang R, Zhu X, Bai H, Ning K (2019) Network pharmacology databases for traditional Chinese medicine: review and assessment. Front Pharmacol 10:123","journal-title":"Front Pharmacol"},{"issue":"6","key":"2070_CR16","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/ATVBAHA.120.314291","volume":"40","author":"X Zhang","year":"2020","unstructured":"Zhang X, Ram\u00edrez CM, Aryal B, Madrigal-Matute J, Liu X, Diaz A et al (2020) Cav-1 (caveolin-1) deficiency increases autophagy in the endothelium and attenuates vascular inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol 40(6):1510\u201322","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2070_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1339647","volume":"15","author":"H Zhang","year":"2024","unstructured":"Zhang H, Mo Y, Wang L, Zhang H, Wu S, Sandai D et al (2024) Potential shared pathogenic mechanisms between endometriosis and inflammatory bowel disease indicate a strong initial effect of immune factors. Front Immunol 15:1339647","journal-title":"Front Immunol"},{"key":"2070_CR13","doi-asserted-by":"crossref","unstructured":"Zhou L, Pan L, Gao J, Jiang Y, Li T, Li R (2025) Diagnostic Biomarkers and Targeted Drug Prediction for Acute Kidney Injury: A Computational Approach. Endocrine, metabolic & immune disorders drug targets","DOI":"10.2174\/0118715303417142250724042300"}],"container-title":["The Science of Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00114-026-02070-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00114-026-02070-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00114-026-02070-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T15:57:10Z","timestamp":1776095830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00114-026-02070-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1007\/s00114-026-02070-x","relation":{},"ISSN":["0028-1042","1432-1904"],"issn-type":[{"value":"0028-1042","type":"print"},{"value":"1432-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not involve human participants, human data or human tissue.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}